Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

CONTEXT A large number of epidemiologic studies have reported on associations between various "inflammatory" factors and coronary heart disease (CHD). OBJECTIVE To assess the associations of blood levels of fibrinogen, C-reactive protein (CRP), and albumin and leukocyte count with the subsequent risk of CHD. DATA SOURCES Meta-analyses of any long-term prospective studies of CHD published before 1998 on any of these 4 factors. Studies were identified by MEDLINE searches, scanning of relevant reference lists, hand searching of cardiology, epidemiology, and other relevant journals, and discussions with authors of relevant reports. STUDY SELECTION All relevant studies identified were included. DATA EXTRACTION The following information was abstracted from published reports (supplemented, in several cases, by the authors): size and type of cohort, mean age, mean duration of follow-up, assay methods, degree of adjustment for confounders, and relationship of CHD risk to the baseline assay results. DATA SYNTHESIS For fibrinogen, with 4018 CHD cases in 18 studies, comparison of individuals in the top third with those in the bottom third of the baseline measurements yielded a combined risk ratio of 1.8 (95% confidence interval [CI], 1.6-2.0) associated with a difference in long-term usual mean fibrinogen levels of 2.9 pmol/L (0.1 g/dL) between the top and bottom thirds (10.3 vs 7.4 pmol/L [0.35 vs 0.25 g/dL]). For CRP, with 1053 CHD cases in 7 studies, the combined risk ratio of 1.7 (95% CI, 1.4-2.1) was associated with a difference of 1.4 mg/L (2.4 vs 1.0 mg/L). For albumin, with 3770 CHD cases in 8 studies, the combined risk ratio of 1.5 (95% CI, 1.3-1.7) was associated with a difference of 4 g/L (38 vs 42 g/L, ie, an inverse association). For leukocyte count, with 5337 CHD cases in the 7 largest studies, the combined risk ratio of 1.4 (95% CI, 1.3-1.5) was associated with a difference of 2.8 x 10(9)/L (8.4 vs 5.6 x 10(9)/L). Each of these overall results was highly significant (P<.0001). CONCLUSIONS The published results from these prospective studies are remarkably consistent for each factor, indicating moderate but highly statistically significant associations with CHD. Hence, even though mechanisms that might account for these associations are not clear, further study of the relevance of these factors to the causation of CHD is warranted.

[1]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[2]  J. Danesh,et al.  Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies , 1998, BMJ.

[3]  A. Siegbahn,et al.  Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 1997, Circulation.

[4]  W. Rutishauser,et al.  C-reactive protein as a marker for acute coronary syndromes. , 1997, European heart journal.

[5]  D. Ardissino,et al.  C-reactive protein elevation and early outcome in patients with unstable angina pectoris. , 1997, The American journal of cardiology.

[6]  E. Topol,et al.  Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase. , 1997, The American journal of cardiology.

[7]  M. Woodward,et al.  Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study , 1997, BMJ.

[8]  A. Folsom,et al.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.

[9]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[10]  Murray Wm Inflammation, aspirin, and the risk of cardiovascular disease. , 1997 .

[11]  F. Niculescu,et al.  Inflammation, aspirin, and the risk of cardiovascular disease. , 1997, The New England journal of medicine.

[12]  S. Ogawa,et al.  C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. , 1997, Circulation.

[13]  G. Assmann,et al.  Coagulation factor VII and the risk of coronary heart disease in healthy men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  G. Frisoni,et al.  Albumin as a predictor of mortality in elderly patients. , 1997, Journal of clinical epidemiology.

[15]  P. Goldwasser,et al.  Association of serum albumin and mortality risk. , 1997, Journal of clinical epidemiology.

[16]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[17]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[18]  P. Elwood,et al.  Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. , 1997, American journal of epidemiology.

[19]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[20]  C. Visser,et al.  C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. , 1997, Circulation.

[21]  E. Feskens,et al.  Serum Albumin, Coronary Heart Disease Risk, and Mortality in an Elderly Cohort , 1997, Epidemiology.

[22]  A. Rumley,et al.  Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study , 1997, British journal of haematology.

[23]  A. Rumley,et al.  Blood rheology and outcome in the West of Scotland Coronary Prevention Study , 1997 .

[24]  P C Elwood,et al.  Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. , 1996, European heart journal.

[25]  P. Hufnagl,et al.  Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. , 1996, Journal of cell science.

[26]  L. Kuller,et al.  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[27]  R. Russell,et al.  Use of albumin as a predictor of mortality in community dwelling and institutionalized elderly populations. , 1996, Journal of clinical epidemiology.

[28]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[29]  A. Pasternack,et al.  Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. , 1996, European heart journal.

[30]  Y. Marcel,et al.  Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. , 1996, Biochemistry.

[31]  J. Guralnik,et al.  Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. , 1996, Journal of clinical epidemiology.

[32]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[33]  E. Feskens,et al.  White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[34]  D. Brunner,et al.  Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[35]  B. Kasiske,et al.  Serum albumin and mortality after renal transplantation. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  D. Strachan,et al.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.

[37]  M. Segal,et al.  Relation of FEV1 and peripheral blood leukocyte count to total mortality. The Normative Aging Study. , 1995, American journal of epidemiology.

[38]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[39]  A. Folsom Epidemiology of fibrinogen. , 1995, European heart journal.

[40]  A. Pezzano,et al.  C-reactive protein and serum amyloid A protein in unstable angina. , 1995, The New England journal of medicine.

[41]  A. Rebuzzi,et al.  973-113 Elevated C-Reactive Protein at Discharge and at Three Months After Waning of Symptoms in Unstable Angina is Associated with Recurrence of Instability During 12 Months Follow-up , 1995 .

[42]  J. Sorkin,et al.  Serum albumin level and physical disability as predictors of mortality in older persons. , 1994, JAMA.

[43]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[44]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[45]  Serum albumin and mortality in the BUPA study. British United Provident Association. , 1994, International journal of epidemiology.

[46]  J. González-Juanatey,et al.  Leukocyte count as a predictor of the severity ischaemic heart disease as evaluated by coronary angiography. , 1993, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[47]  T. Meade,et al.  Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.

[48]  G. Specchia,et al.  Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease , 1993, Circulation.

[49]  G. Vercellotti,et al.  C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor , 1993 .

[50]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[51]  J. Stamler,et al.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. , 1993, The Journal of clinical investigation.

[52]  R. Gillum,et al.  White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. , 1993, American heart journal.

[53]  P. Ducimetiere,et al.  Monocyte count: a risk factor for coronary heart disease? , 1993, American journal of epidemiology.

[54]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[55]  D. Cook,et al.  Leukocyte count and risk of major coronary heart disease events. , 1992, American journal of epidemiology.

[56]  J. Huttunen,et al.  Leukocytes as a coronary risk factor in a dyslipidemic male population. , 1992, American heart journal.

[57]  L. Welin,et al.  Social network and activities in relation to mortality from cardiovascular diseases, cancer and other causes: a 12 year follow up of the study of men born in 1913 and 1923. , 1992, Journal of epidemiology and community health.

[58]  K. Anderson,et al.  White blood cell count and cardiovascular disease. Insights from the Framingham Study. , 1992, JAMA.

[59]  E. Barrett-Connor,et al.  Albumin levels as a predictor of mortality in the healthy elderly. , 1992, Journal of clinical epidemiology.

[60]  M. Burr,et al.  Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). , 1992, European heart journal.

[61]  D. Cook,et al.  The leukocyte count and risk of lung cancer , 1992, Cancer.

[62]  R. Gillum,et al.  Serum albumin, coronary heart disease, and death. , 1992, American heart journal.

[63]  M. Chung,et al.  Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? , 1992, The American journal of medicine.

[64]  M. Burr,et al.  Influence of platelet size on outcome after myocardial infarction , 1991, The Lancet.

[65]  L H Kuller,et al.  The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. , 1991, American journal of epidemiology.

[66]  S. Yasumura,et al.  Longitudinal changes of serum albumin in elderly people living in the community. , 1991, Age and ageing.

[67]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.

[68]  W. Thompson,et al.  Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[69]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[70]  P. Ducimetiere,et al.  Serum albumin and mortality , 1990, The Lancet.

[71]  R J Glynn,et al.  White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. , 1990, Journal of clinical epidemiology.

[72]  P. Whincup,et al.  ASSOCIATION BETWEEN SERUM ALBUMIN AND MORTALITY FROM CARDIOVASCULAR DISEASE, CANCER, AND OTHER CAUSES , 1989, The Lancet.

[73]  P. Taylor,et al.  Body iron stores and the risk of cancer. , 1988, The New England journal of medicine.

[74]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[75]  V. Nguyen Fibrinogen and risk of cardiovascular disease: Kannel WB, Wolf PA, Castelli WP, et al JAMA 258: 1183–1186 Sep 1987 , 1988 .

[76]  R. Cotran,et al.  The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[77]  M. J. Mitchinson,et al.  MACROPHAGES AND ATHEROGENESIS , 1987, The Lancet.

[78]  J. Dormandy,et al.  Leukocytes and the risk of ischemic diseases. , 1987, JAMA.

[79]  R. Stevens,et al.  Iron-binding proteins and risk of cancer in Taiwan. , 1986, Journal of the National Cancer Institute.

[80]  D. Petitti,et al.  The leukocyte count: associations with intensity of smoking and persistence of effect after quitting. , 1986, American journal of epidemiology.

[81]  M. C. Stone,et al.  Plasma fibrinogen--a major coronary risk factor. , 1985, The Journal of the Royal College of General Practitioners.

[82]  C. Forbes,et al.  White Blood Cell Count and Haematocrit as Predictors of Coronary Recurrence after Myocardial Infarction , 1985, Thrombosis and Haemostasis.

[83]  P. Ueland,et al.  Radioenzymic determination of homocysteine in plasma and urine. , 1985, Clinical chemistry.

[84]  P. Ducimetière,et al.  La baisse du taux de la fraction albumine-alpha-1 globuline des protéines sériques, facteur de risque des cardiopathies ischémiques , 1985 .

[85]  M. Pepys,et al.  C-reactive protein: binding to lipids and lipoproteins. , 1985, International review of experimental pathology.

[86]  H. Shibata,et al.  [Relationship of serum albumin concentration to aging and survivorship in the community volunteers aged 70]. , 1984, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[87]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[88]  Jonathan Scott Friedlaender,et al.  Iron-binding proteins, hepatitis B virus, and mortality in the Solomon Islands. , 1983, American journal of epidemiology.

[89]  M. Pepys,et al.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.

[90]  R. Prentice,et al.  Leukocyte counts and coronary heart disease in a Japanese cohort. , 1982, American journal of epidemiology.

[91]  J. Kostis,et al.  Association of recurrent myocardial infarction with hemostatic factors: a prospective study. , 1982, Chest.

[92]  A. Maseri,et al.  Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. , 1982, British heart journal.

[93]  J. Richard,et al.  Leukocyte count, smoking, and myocardial infarction. , 1981, The New England journal of medicine.

[94]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[95]  A. Siegelaub,et al.  The leukocyte count as a predictor of myocardial infarction. , 1974, The New England journal of medicine.

[96]  P. White,et al.  The natural history of coronary heart disease , 1970 .